US semiconductor stocks rebound as ARM surges 11% in pre-market rally

source:

[1] Micron Stock Has Surged 637% in a Year. History Has a Clear Answer Where It Will Be in 2027 (https://www.msn.com/en-us/money/topstocks/mic ...)[2] ASX 200 Live Today - Thursday, 30th July (https://www.marketindex.com.au/news/asx-200-l ...)[3] Wall Street closes down sharply after Fed holds rates unchanged (https://www.msn.com/en-us/money/markets/wall- ...)[4] S&P 500, Nasdaq futures edge higher ahead of Fed decision (https://www.msn.com/en-my/news/other/s-p-500- ...)

Related News

Jul 30 2026, 14:57

Acadian Asset Management beats Q2 estimates as AUM surges 54%

Acadian Asset Management reported Q2 EPS of $1.33, beating the $1.03 consensus by 29.8% as assets under management surged 54% to $232.7 billion. "The strong investment performance across 96% of strategies by revenue drove record management fees," the Boston-based quantitative asset manager said in its earnings release. Revenue of $185.1 million topped the $173 million consensus estimate by 7.1%, while record management fees of $176.5 million pushed operating margins to 40.3%, up nearly 10 percentage points from a year earlier. Adjusted revenue came in at $183.2 million. Net income reached $27.3 million, or 76 cents per share on a GAAP basis, compared with $0.64 per share in the year-ago quarter. On an adjusted basis, EPS of $1.33 more than doubled from $0.64 a year earlier, representing 107% year-over-year growth. The beat was driven by higher-than-expected management fees from the surge in AUM, as the company's systematic strategies generated strong investment performance that attracted additional client inflows. | Metric | Actual | Consensus | Beat/Miss | |--------|--------|-----------|-----------| | Revenue | $185.1M | $173M | +7.1% | | EPS (adjusted) | $1.33 | $1.03 | +29.8% | | Operating margin | 40.3% | — | +990bps YoY | The company has now posted 10 consecutive quarters of positive net client cash flows, reflecting sustained demand for its systematic investment strategies. The AUM growth from about $151 billion a year earlier reflects both market appreciation and net inflows across its global institutional client base. Acadian offers institutional investors access to a diversified array of systematic strategies across global equity, fixed income, and alternative markets. The firm's quantitative approach, which uses systematic models to drive investment decisions, has attracted inflows at a time when many traditional active managers have faced persistent outflows. The company held a conference call at 11 a.m. Eastern time on July 30 to discuss the results with analysts and investors. Shares of Acadian have gained 72% year to date and have more than doubled over the past 12 months, outperforming the broader asset management sector. The rally reflects investor confidence in the firm's ability to sustain organic growth and margin expansion. The stock's performance stands in contrast to some traditional active managers that have struggled with outflows and fee compression in recent years. Acadian's operating margin of 40.3% places it among the most profitable publicly traded asset managers, with the 990-basis-point year-over-year expansion driven by the scale benefits of higher AUM. The earnings beat reinforces the momentum for quantitative asset managers as institutional investors increase allocations to systematic strategies. With AUM growing 54% year over year and operating margins expanding sharply, Acadian has demonstrated the operating leverage inherent in the asset management model. Investors will watch the company's Q3 2026 earnings report for continued AUM growth and margin trends. *This article is for informational purposes only and does not constitute investment advice.*

Jul 30 2026, 14:52

Nuclea Energy to go public via $0M Mangoceuticals deal for microreactor

**A Canadian advanced nuclear developer is taking a faster route to the public markets, betting that surging AI-driven electricity demand will accelerate demand for factory-built microreactors.** Nuclea Energy Inc., a Mississauga, Ontario-based developer of the Morpheus lead-cooled microreactor, has entered into a definitive business combination agreement with Mangoceuticals Inc. (NASDAQ: MGRX), a men's health telemedicine company, the companies said July 30. The deal gives Nuclea a Nasdaq listing without a traditional IPO, at a time when U.S. electricity demand is projected to rise sharply after two decades of being largely flat. "The scale of capital being committed to power the AI build-out is enormous, and we believe advanced nuclear and microreactors will be a critical part of how that demand is met," Jacob Cohen, chief executive officer of Mangoceuticals, said in a statement. The Morpheus reactor is a lead-cooled, graphite-moderated design in the conceptual stage, scalable from 3.5 MWe to 50 MWe. Its lead coolant operates at near-atmospheric pressure with a high boiling point, enabling passive natural-convection cooling that requires no pumps — a safety feature that eliminates the need for water or steam inside the reactor. Nuclea has developed a patent-pending annular fuel configuration designed to extend refueling cycles to as long as five years, compared with the industry standard of 1.5 years. The core module, roughly 3 cubic meters, is designed for factory fabrication and transport via standard rail and road shipping. The transaction structure includes a Nasdaq cap limiting the combined economic and voting rights of Nuclea shareholders to 19.99% of Mangoceuticals' outstanding common stock until stockholder and Nasdaq approvals are obtained. Following those approvals, the exchangeable shares will convert to full voting and economic rights. Joseph Gunnar & Co. is serving as exclusive financial advisor. **Policy tailwinds and data center demand** The advanced nuclear sector is benefiting from significant U.S. policy support. The bipartisan ADVANCE Act, signed into law in July 2024, directs the Nuclear Regulatory Commission to develop microreactor-specific licensing guidance within 18 months, reduces fees for advanced reactor applicants and authorizes prizes for first movers. The Department of Energy has also re-issued a $900 million solicitation focused on commercial deployment of American-made small modular reactors, with up to $800 million earmarked for first-mover utility-vendor-constructor teams. These policy measures align with a structural shift in electricity demand. The build-out of artificial intelligence infrastructure and hyperscale data centers is driving a generational expansion in U.S. power consumption. On July 29, Brookfield Asset Management and NextEra Energy announced plans to develop a $100 billion data center campus at a former DOE uranium enrichment site in Paducah, Kentucky, providing more than 1.2 GW of computing capacity and up to 1.8 GW of electricity to the grid, with operations targeted from 2028. Nuclea's leadership team combines technical and regulatory expertise. Josef Freundorfer, chief executive officer, also serves as president of Nuclear Potential Canada. Dr. Eleodor Nichita, co-founder and head of reactor design, is an associate professor at Ontario Tech University and former president of the Canadian Nuclear Society. The advisory board includes Jay Patel, a former NRC nuclear safety specialist, and Dr. Michael Binder, former president and CEO of the Canadian Nuclear Safety Commission from 2008 to 2018. The company is pursuing regulatory pathways in Canada through the CNSC Vendor Design Review process and in the United States through NRC Standard Design Approval, with preliminary pre-application engagements completed. Nuclea targets applications across data centers, defense installations, remote mining operations and off-grid communities currently reliant on diesel generation. **Investment implications** The transaction positions Mangoceuticals as a de facto nuclear microreactor pure play upon deal completion, giving retail investors exposure to a sector that has historically been accessible only through larger players like NuScale Power (NYSE: SMR) or Oklo Inc. (NYSE: OKLO). Nuclea's Morpheus remains in the conceptual design stage with an 18-month development roadmap toward regulatory and commercial readiness, meaning the company carries significant technology and licensing risk before generating revenue. The closing is expected before required stockholder and Nasdaq approvals are obtained, with a full S-4 registration statement to follow. This article is for informational purposes only and does not constitute investment advice.

Jul 30 2026, 14:50

Goldman Sachs launches AlphaAI in 2026 AI investing push

Goldman Sachs Asset Management launched AlphaAI, an artificial intelligence investing platform, betting that machine-learning models will drive investment returns across its public and private market businesses, according to a memo seen by Reuters. The memo, sent to staff Thursday, described AlphaAI as a firmwide initiative embedding AI models into portfolio construction, risk management and trade execution across asset classes. The platform will initially focus on equities and fixed income before expanding into private credit and real estate, the memo showed. Goldman Sachs has not disclosed the size of the investment or the number of personnel assigned to the initiative. Goldman Sachs joins BlackRock, Morgan Stanley and JPMorgan Chase in investing heavily in AI tools for investment management. BlackRock has integrated AI into its Aladdin risk platform, which manages more than $20 trillion in assets. Morgan Stanley deployed large language models from OpenAI for its 15,000-plus financial advisors. JPMorgan allocates more than $17 billion annually to technology, with a growing share directed toward AI and machine learning, according to its most recent annual report. The launch reflects Goldman Sachs' view that AI will reshape the global asset management industry, which oversees more than $100 trillion in assets. Early adopters could gain a sustained edge in generating alpha, putting pressure on rivals to accelerate their own AI initiatives. **A Growing AI Arms Race in Asset Management** Wall Street's largest asset managers are competing to integrate generative AI and machine learning into their core operations. Goldman Sachs has been building AI capabilities across the firm, including its Marquee platform for institutional clients and its engineering division. The competition for AI talent has intensified, with asset managers poaching data scientists and quantitative researchers from technology companies and hedge funds. The push into AI comes as the asset management industry faces pressure to lower fees and improve returns. Passive investing has captured more than half of all US fund assets, squeezing margins for active managers. AI-driven strategies offer a potential path to generating alpha without the high cost of traditional active management teams. Goldman Sachs Asset Management, one of the largest asset managers globally, has been expanding its alternatives business, including private equity, private credit and real estate, where AI models could help source deals and underwrite investments. The firm's ability to deploy AI across both public and private markets distinguishes AlphaAI from more narrowly focused AI initiatives at competing firms. **What AlphaAI Means for Investors** The platform's success will depend on its ability to generate consistent risk-adjusted returns that outperform traditional strategies. Goldman Sachs has not disclosed performance targets or fee structures for AlphaAI-managed strategies. The firm is expected to provide more details in its upcoming investor day, though a date has not been announced. For institutional investors, AlphaAI represents a bet that machine-learning models can identify patterns and opportunities that human analysts miss. If successful, the platform could attract significant inflows from pension funds, endowments and sovereign wealth funds seeking higher returns. If it fails to deliver, it could set back the broader push toward AI in asset management. The launch also raises questions about the future role of human portfolio managers. While Goldman Sachs has described AlphaAI as a tool to augment human decision-making, the platform's expansion into more asset classes could eventually reduce the number of traditional fund managers needed. The firm has not commented on potential headcount implications. This article is for informational purposes only and does not constitute investment advice.